Enovis (ENOV) Accumulated Depreciation & Amortization (2010 - 2025)

Enovis (ENOV) reported Accumulated Depreciation & Amortization of $1.3 billion for Q4 2025, up 44.87% year-over-year from $927.8 million in Q4 2024, and up 44.87% quarter-over-quarter from $927.8 million in Q4 2024.

Enovis (ENOV) Accumulated Depreciation & Amortization (2010 - 2025) Analysis & Trends

Enovis (ENOV) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $1.3 billion in Q4 2025.

  • Accumulated Depreciation & Amortization for Q4 2025 came in at $1.3 billion, up 44.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 44.87% YoY), and the FY2025 annual result was $1.3 billion, up 44.87% from the prior year.
  • Accumulated Depreciation & Amortization grew to $1.3 billion in Q4 2025 per ENOV's latest filing, from $927.8 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $1.3 billion in Q4 2025 and troughed at $217.1 million in Q4 2023.
  • A 5-year average of $594.3 million and a median of $262.9 million in 2021 frame the typical range for Accumulated Depreciation & Amortization.
  • The sharpest annual moves came in 2022 and 2024: Accumulated Depreciation & Amortization slipped 16.43% in 2022, then jumped 327.36% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $262.9 million in 2021, then declined by 16.43% to $219.7 million in 2022, then dropped by 1.18% to $217.1 million in 2023, then jumped by 327.36% to $927.8 million in 2024, then soared by 44.87% to $1.3 billion in 2025.
  • Business Quant data shows ENOV's Accumulated Depreciation & Amortization at $1.3 billion in Q4 2025, $927.8 million in Q4 2024, and $217.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Enovis 1.24 Bn 1.21 Bn 365.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.34 Bn
Dec 31, 2025 1.34 Bn
Dec 31, 2024 927.83 Mn
Dec 31, 2024 927.83 Mn
Dec 31, 2023 217.11 Mn
Dec 31, 2023 217.11 Mn
Dec 31, 2022 219.71 Mn
Dec 31, 2022 219.71 Mn
Dec 31, 2021 262.92 Mn
Dec 31, 2021 262.92 Mn
Dec 31, 2020 246.23 Mn
Dec 31, 2020 246.23 Mn
Dec 31, 2019 236.03 Mn
Dec 31, 2019 236.03 Mn
Dec 31, 2018 141.88 Mn
Dec 31, 2018 141.88 Mn
Dec 31, 2017 132.20 Mn
Dec 31, 2017 132.20 Mn
Dec 31, 2016 137.18 Mn
Dec 31, 2016 137.18 Mn